article thumbnail

Despite Safety and Supply Challenges, Outsourcing IV Compounding Remains High

Omnicell

Stephanie Gallagher, PharmD, MBA Senior Clinical Product Marketing Manager, Omnicell The sterile compounding industry has been under great scrutiny due to alarming frequency and severity of adverse events from IV compounding, such as the New England Compounding Center catastrophe in 2012.

article thumbnail

Building the Case for Dedicated 340B Program Management

Omnicell

Lisa Armburger Director, Client Success Executive, Omnicell 340B The pressures of the last year have underscored the importance of the 340B program and its impact on hospital finances. Download our recent eBook to access the tools you need to build a business case around the value of a dedicated 340B program manager.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

A 340B advocacy group punching above its weight

Omnicell

Not only was the organization the first to sue the government, but it has also provided a great public service by developing a helpful tracking tool that you can download and other resources on the ongoing contract pharmacy battle.

article thumbnail

A 340B Pricing Success Story and Recommendations for Improvement

Omnicell

Madeline Wallack, a co-author of the OIG reports and co-founder of consulting firm Rx|X, points out that the database is underutilized since the pricing files are not downloadable. As a result, it is difficult for her clients to conduct widescale price comparisons against wholesaler files.

article thumbnail

A 340B Pricing Success Story and Recommendations for Improvement

Omnicell

Madeline Wallack, a co-author of the OIG reports and co-founder of consulting firm Rx|X, points out that the database is underutilized since the pricing files are not downloadable. As a result, it is difficult for her clients to conduct widescale price comparisons against wholesaler files.